Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer

Genome-wide analysis using microarrays has revolutionized breast cancer (BC) research. A substantial body of evidence supports the clinical utility of the 21-gene assay (Oncotype DX) and 70-gene assay (MammaPrint) to predict BC recurrence and the magnitude of benefit from chemotherapy. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Kneubil, M.C., Goulart, K.O.B., Brollo, J., Coelho, G.P., Mandelli, J., Orlandin, B.C., Corso, L.L., Roesch-Ely, M., Henriques, J.A.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922549/
https://www.ncbi.nlm.nih.gov/pubmed/35293552
http://dx.doi.org/10.1590/1414-431X2021e11857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922549/
https://www.ncbi.nlm.nih.gov/pubmed/35293552
http://dx.doi.org/10.1590/1414-431X2021e11857

Ejemplares similares